ABLA

Alan B. Lancz & Associates Portfolio holdings

AUM $99.9M
This Quarter Return
+11.31%
1 Year Return
+15.58%
3 Year Return
5 Year Return
10 Year Return
AUM
$114M
AUM Growth
Cap. Flow
+$114M
Cap. Flow %
100%
Top 10 Hldgs %
35.37%
Holding
147
New
147
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

1 Technology 22.91%
2 Communication Services 15.13%
3 Healthcare 12.87%
4 Financials 9.88%
5 Industrials 9.61%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ABBV icon
26
AbbVie
ABBV
$374B
$942K 0.82%
+6,960
New +$942K
GS icon
27
Goldman Sachs
GS
$221B
$937K 0.82%
+2,450
New +$937K
PSMT icon
28
Pricesmart
PSMT
$3.32B
$930K 0.81%
+12,710
New +$930K
MMM icon
29
3M
MMM
$82.2B
$909K 0.79%
+5,120
New +$909K
AOS icon
30
A.O. Smith
AOS
$9.86B
$860K 0.75%
+10,014
New +$860K
MDT icon
31
Medtronic
MDT
$120B
$853K 0.75%
+8,248
New +$853K
MKC icon
32
McCormick & Company Non-Voting
MKC
$18.5B
$841K 0.74%
+8,700
New +$841K
BX icon
33
Blackstone
BX
$132B
$822K 0.72%
+6,350
New +$822K
GILD icon
34
Gilead Sciences
GILD
$140B
$805K 0.7%
+11,090
New +$805K
NVDA icon
35
NVIDIA
NVDA
$4.16T
$794K 0.69%
+2,700
New +$794K
T icon
36
AT&T
T
$208B
$785K 0.69%
+31,921
New +$785K
DEO icon
37
Diageo
DEO
$61.5B
$755K 0.66%
+3,431
New +$755K
FDX icon
38
FedEx
FDX
$52.9B
$750K 0.66%
+2,900
New +$750K
AMT icon
39
American Tower
AMT
$93.9B
$717K 0.63%
+2,450
New +$717K
BAX icon
40
Baxter International
BAX
$12.4B
$717K 0.63%
+8,350
New +$717K
LUMN icon
41
Lumen
LUMN
$4.92B
$693K 0.61%
+55,210
New +$693K
JPM icon
42
JPMorgan Chase
JPM
$824B
$684K 0.6%
+4,317
New +$684K
NOK icon
43
Nokia
NOK
$22.8B
$681K 0.6%
+109,411
New +$681K
ALL icon
44
Allstate
ALL
$53.6B
$676K 0.59%
+5,750
New +$676K
APD icon
45
Air Products & Chemicals
APD
$65B
$669K 0.58%
+2,200
New +$669K
CME icon
46
CME Group
CME
$95.6B
$668K 0.58%
+2,925
New +$668K
LLY icon
47
Eli Lilly
LLY
$659B
$665K 0.58%
+2,406
New +$665K
GSK icon
48
GSK
GSK
$78.5B
$654K 0.57%
+14,825
New +$654K
HD icon
49
Home Depot
HD
$404B
$630K 0.55%
+1,518
New +$630K
BMY icon
50
Bristol-Myers Squibb
BMY
$96.5B
$620K 0.54%
+9,950
New +$620K